Product Information
PREGABALIN 150 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0542 per EA under NDC 65862076290. Its NADAC has been published 138 times since Feb 14, 2024.
FDA first approved this application on Mar 29, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862076290
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA205321FDA Approved
3/29/2023
TE Code
AB
On Market Since
3/29/2023
Price Statistics
The NADAC for PREGABALIN 150 MG CAPSULE has been published 138 times since Feb 14, 2024, and over the history we have for it it has declined 23.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0542 per EA |
|---|---|
| All-time high | $0.0722 (Oct 16, 2024) |
| All-time low | $0.0489 (Jul 22, 2026) |
| 52-week high | $0.0582 |
| 52-week low | $0.0489 |
| Median price | $0.0582 |
| Average price | $0.0594 |
| Largest weekly change | +32.6% (Aug 21, 2024) |
| Weeks tracked | 138 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pregabalin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREGABALIN 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 150 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.0542 per EA (NDC 65862076290), effective Sep 30, 2026.
How has the price of PREGABALIN 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 150 MG CAPSULE has declined 23.9%. It has been tracked across 138 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for PREGABALIN 150 MG CAPSULE?
Since Feb 14, 2024, the NADAC for PREGABALIN 150 MG CAPSULE has ranged from a low of $0.0489 (Jul 22, 2026) to a high of $0.0722 (Oct 16, 2024), with a median of $0.0582 per EA.
Are there cheaper alternatives to PREGABALIN 150 MG CAPSULE?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 150 MG CAPSULE, is $0.0519 per EA — about 4% below PREGABALIN 150 MG CAPSULE.
Who manufactures PREGABALIN 150 MG CAPSULE?
PREGABALIN 150 MG CAPSULE (NDC 65862076290) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.